Public Health and Social Services Emergency Fund
Schedules
TAFS: 075-0140 /X - Public Health and Social Services Emergency Fund
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1000 | DE | Discretionary Expected Unob Bal: Brought forward, Oct 1 | $982,327,051 | |
| 1000 | ME | Mandatory Expected Unob Bal: Brought forward, Oct 1 | $1,233,448,671 | |
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $10,000,000 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $2,225,775,722 | ||
| 6001 | Category A -- 1st quarter | $17,242 | ||
| 6011 | PHSSEF Reimbursables | $10,000,000 | ||
| 6013 | Strategic National Stockpile | $38,000,000 | ||
| 6015 | Pandemic Influenza (Vaccines, Antivirals & Diagnostics) | $28,000,000 | ||
| 6016 | Pandemic Influenza (Facilities, Vaccines, Antivirals, and Diagnostics) | $23,000,000 | ||
| 6017 | Pandemic Influenza (Other HHS Activities) | $8,609,126 | ||
| 6018 | Pandemic Influenza (Other CDC Activities) | $2,519,958 | ||
| 6019 | Parklawn Lease Replacement | $267 | ||
| 6021 | Haiti CDC | $601,737 | ||
| 6022 | Haiti ACF | $52,997 | ||
| 6023 | Haiti ASPR | $117,539 | ||
| 6024 | HHS Lease Replacements | $622,937 | ||
| 6025 | Project BioShield | $42,000,000 | ||
| 6026 | Pandemic Influenza | $8,275,000 | ||
| 6027 | NDMS | $429,603 | ||
| 6028 | Bioterrorism | $409,222 | ||
| 6029 | CDC Capacity | $306,206 | ||
| 6030 | Natural Disasters | $4,888,792 | ||
| 6032 | CDC Preparedness | $175,229 | ||
| 6037 | Coronavirus 2 Testing for the Uninsured | $4,600,203 | ||
| 6038 | Coronavirus 3 Healthcare Provider Reimbursements | $122,941,433 | ||
| 6039 | Coronavirus 4 Healthcare Provider Reimbursements | $319,279,384 | ||
| 6040 | Coronavirus 4 Allocations to State, Local, Tribal and other entities | $347,562,776 | ||
| 6041 | Coronavirus 4 BARDA | $7,917,400 | ||
| 6044 | Coronavirus 4 HHS Response Activities | $22,000,000 | ||
| 6047 | Coronavirus 6 Healthcare Provider Reimbursements | $3,882,817 | ||
| 6048 | Coronavirus 6 Testing, Contact Tracing, and Mitigation Activities | $1,153,743,876 | ||
| 6049 | Coronavirus 6 Public Health Workforce | $50,254,513 | ||
| 6051 | Coronavirus 6 Antivirals | $21,372,816 | ||
| 6052 | Coronavirus 6 Vaccines, Therapeutics, and Medical Supplies | $4,194,649 | ||
| 6190 | Total budgetary resources available | $2,225,775,722 | See footnotes below | |
| Footnotes for line 6190: | A1: The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. | |||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for additional spending authority from reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.